It was reported that on (b)(6) 2012, the patient underwent a stenting procedure with placement of a 7-10 x 40 mm acculink stent in the left internal carotid artery.On (b)(6) 2014, the patient was re-hospitalized with right-sided numbness, bilateral weakness and hypertension.A transient ischemic attack was diagnosed.Doppler ultrasound indicated that there was in-stent restenosis in the acculink stent.Medications were administered; however, no additional intervention was performed.The patient's condition continues and the patient was discharged to home on (b)(6) 2014.No additional information was provided.
|
(b)(4).During processing of this complaint, attempts were made to obtain complete event, patient and device information.There was no reported device malfunction, and the product was not returned.The reported patient effects of neurological deficit/dysfunction and stenosis are known observed and potential patient effects as listed in the rx acculink, domestic, instructions for use (ifu).Although a conclusive cause for the reported patient effects, and the relationship to the product, if any, cannot be determined, there is no indication of a product quality deficiency with respect to manufacturing, design or labeling.A review of the lot history record revealed no non-conformances that would have contributed to the reported event.Based on the information reviewed, there is no indication of a product deficiency.
|